Introduction for Glabridin and tyrosinase
Chloasma is an unclear, irregularly-shaped pale brown spot on the facial skin centered on the humerus. Although some factors related to the disease and aggravating symptoms are known, the underlying cause remains unclear. A variety of treatments have been developed and are still not satisfied. Although Glabridin and tyrosinase could treating chloasma, in order to improve the therapeutic effect of chloasma, it is necessary to clarify its pathogenesis; the significance of pigment, blood vessel, inflammatory reaction and impaired skin barrier function in the pathogenesis of chloasma .
The chloasma standard is formulated as follows:
1 after 16 years of age, acquired facial pigmentation spots;
2 pale brown to dark brown diffuse stains, sometimes appearing in a network, the boundaries are unclear;
3 symptoms will change, more common in women ;
4 basically no incentives such as trauma. Among the patients diagnosed with chloasma, those who require treatment are selected, and the causes of their onset are sun exposure, mental factors, gynecological problems, pregnancy, heredity, oral contraceptives, topical cosmetics, unexplained reasons, etc.
Glabridin and tyrosinase was performed once a month after the start of treatment, a total of 3 times. Each time, a review is conducted after one month to observe the effects before and after treatment and to inquire about the patient's sensory state. Based on what is known, the clinician compares the actual conditions of the photographs taken and evaluates the extent of skin recovery and the extent of skin damage. The judgment of treatment can also be divided into four levels: no obvious effect, slowly getting better, and the pigment state has obviously subsided, and it has been basically cured.
By tracking the 150 patients after treatment, Using Glabridin and tyrosinase 90% of the patients had faded or reduced the color of the pigmentation within 1 to 3 months of the initial treatment. Twenty-three percent of patients had different degrees of black return within 15 days after microneedle treatment, and returned to normal after one month. 47% of patients started to have pigmentation at 2 months of treatment. The specific treatment was 1, 2, and 3 months. See Table 2, no recurrence of melasma has been found after the end of treatment. Three of them were allergic to lidocaine epidermis anesthesia before microneedle treatment, and the remaining patients did not have obvious allergic reactions or other adverse reactions. Overall, the patient's satisfaction was above 90% by using Glabridin and tyrosinase.
Carton: 1kg with double plastic container inside/Aluminum foil bag outside;
25kg with double plastic container inside/Fiber drum outside.
or as customer’s requirement.
Suitable for ≤50kgs
Door to Door
Easy Pick Up Goods
Suitable for ≥50kgs
Airport to Airport
Pick Up Goods by Customer
Suitable for ≥500kgs
Port to Port
Pick Up Goods by Customer
Send your inquiry Details in the below for free sample, Click "Send" Now!